Cerebral venous thrombosis after caesarean section

Czech version

Authors: Drábková Lucie
Authors‘ workplace: Gynekologicko-porodnické oddělení, Nemocnice Ivančice, p. o.
Published in: Ceska Gynekol 2021; 86(5): 339-342
Category: Case Report
doi: https://doi.org/10.48095/cccg2021339

Overview

Objective: Case report of a patient with cerebral venous thrombosis after caesarean section. Case report: We present a case of a 22-year-old patient after an acute caesarean section, which was complicated by cerebral venous thrombosis. The etiology of the thrombosis was multifactorial. Diagnosis was determined using imaging methods once the neurological symptoms were expressed. Follow-up care for the patient included comprehensive care in the intensive care unit, including a temporary decompresive craniectomy. Conclusion: Cerebral venous thrombosis is a rare disease with a varied clinical manifestation whose development is affected by a number of acquired and congenital factors. The incidence is increased in women in the puerperium, but we can also see it in gynecological practice in young contraception users. Contextual knowledge is essential in early diagnosis as well as using a correct treatment strategy with a multidisciplinary approach and interdisciplinary collaboration.

Keywords:

caesarean section – headache – cerebral venous thrombosis – laparotomy dehiscence

Sources

1. Neumann J, Roubec M, Školoudík D et al. Trombóza mozkových žil a splavů. In: Školoudík D, Šaňák D et al (eds). Rekanalizační terapie akutní ischemické cévní mozkové příhody. Praha: Maxdorf 2013: 217–230.

2. Smetanskyi V, Šefčíková A, Dörr A. Mozková žilní trombóza v těhotenství. Ceska Gynekol 2018; 83 (2): 123–126.

3. Štětkářová I et al. Moderní farmakoterapie v neurologii. Praha: Maxdorf 2017.

4. Tomek A. Neurointenzivní péče. Edice postgraduální medicíny. 3. vyd. Praha: Mladá fronta 2018: 352–357.

5. Furie KL, Cushman M, Elkind MS et al. American Heart Association/American Stroke Association Stroke Council Leadership. Diagnosis and management of cerebral venous sinus thrombosis with vaccine-induced immune thrombotic thrombocytopenia. Stroke 2021; 52 (7): 2478–2482. doi: 10.1161/STROKEAHA.121.035564

6. Ferro JM, Canhão P, Stam J et al. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 2004; 35 (3): 664–670. doi: 10.1161/01.STR.0000117571.76197.26.

7. Bajko Z, Motataianu A, Stoian A et al. Postpartum cerebral venous thrombosis – a single-center experience. Brain Sci 2021; 11 (3): 327. doi: 10.3390/ brainsci11030327.

8. Meng R, Wang X, Hussain M et al. Evaluation of plasma D-dimer plus fibrinogen in predicting acute CVST. Int J Stroke 2014; 9 (2): 166–173. doi: 10.1111/ijs.12034.

9. Neumann J, Pouzar J, Macko J et al. Mozková žilní trombóza u mladých žen. Med praxi 2015; 12 (2): 92–94.

10. Barboza MA, Chiquete E, Arauz A et al. A practical score for prediction of outcome after cerebral venous thrombosis. Front Neurol 2018; 9: 882. doi: 10.3389/fneur.2018.00882.

11. Taquet M, Husain M, Geddes JR et al. Cerebral venous thrombosis and portal vein thrombosis: a retrospective cohort study of 537,913 COVID-19cases. EClinicalMedicine 2021; 39: 101061. doi: 10.1016/j.eclinm.2021.101061.